Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acknowledged, adenocarcinoma, adenoma, advent, agreementthrough, Archer, array, Assoc, Austin, autoanalyzer, Bee, binding, book, borrowing, broker, calibrant, Cave, chemiluminescent, chemotherapy, chromatin, clonal, coated, Codification, coiled, compact, Companyraised, constrained, core, CSA, decade, digested, Digestion, disc, dissemination, distributor, dual, DX, EGFR, elderly, encoding, essence, exquisite, forfeited, forup, Foundation, Galleria, Gibb, GmbH, GRAIL, hematological, host, implicit, inaccessible, inactivating, inappropriately, incremental, ineffectual, isolate, kidney, Koninklijke, length, licensee, liver, magnetic, magnitude, mechanism, mediated, molecule, Motif, muscle, NCI, neoplasia, neoplastic, Octamer, outset, ovarian, overnight, Parkway, partly, PerShare, Phillip, preoperatively, prescribed, radiation, reagent, recipe, recombinant, redefine, reinforce, revolutionized, ROU, Sadler, signal, signaling, similarly, simplistic, stream, supercoiled, suppressor, TheEuropean, thereunderfor, Thrive, tissueremoved, transcribing, transcription, triple, UDI, unannounced, unchanged, undergoing, undetectable, unwound, upfront, uterine, Vet, wrapped
Removed:
accident, aftermath, aid, Antigen, attack, bead, biobank, bisulfite, car, Chroma, CHU, Cologuard, Communicating, competitor, concept, conversion, counsel, culminating, dense, die, dying, ELISA, Epi, exclusively, expired, falling, fecal, FINRA, FIT, flexible, fourth, frontline, guaiac, habib, half, heart, high, illustrated, immense, immunochemical, Importantly, inflammatory, informed, leased, leaving, methylated, moderate, molecular, monitor, nuclear, outweigh, overwhelm, packaged, packing, pancreatic, PCR, plasma, polymerase, preferred, proColon, proLung, prostate, PSA, publicly, purely, reaction, reclassified, recommended, recycled, recycling, rest, sensitivity, serum, sigmoidoscopy, skaff, Society, specificity, sputum, straight, structuring, switching, Task, thereunder, traditional, transitioning, trauma, treble, UCL, underway, uniform, urine, valuable, virtual
Filing tables
Filing exhibits
- 10-K Annual report
- 4.1 Exhibit 4.1 Description of Capital Stock
- 10.22 Exhibit 10.22 Amendment No. 1 to Clinical Study Agreement
- 21.1 Exhibit 21.1 Subsidiaries of Volitionrx Limited
- 23.1 Exhibit 23.1 Auditor's Consent
- 31.1 Exhibit 31.1 Section 302 Certification
- 31.2 Exhibit 31.2 Section 302 Certification
- 32.1 Exhibit 32.1 Section 906 Certification
- Download Excel data file
- View Excel data file
Related press release
Associated VNRX transcripts
VNRX similar filings
Filing view
External links
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Audit Committee
VolitionRx Limited
As independent registered public accountants, we hereby consent to the incorporation by reference of our report dated February 20, 2020, contained in this annual report on Form 10-K with respect to the consolidated financial statements of VolitionRx Limited, in its registration statements on Form S-3 (Registration Statement Nos. 333-195213, 333-227248, 333-227731 and 333-236335) and its registration statements on Form S-8 (Registration Statement Nos. 333-208512, 333-214118, 333-221054, 333-227565 and 333-236336).
/s/ Sadler Gibb & Assoc.
Sadler, Gibb & Associates, LLC
Salt Lake City, UT
February 20, 2020